Pulpy Kidney

Description

Clostridium Perfingens. Source: Wikimedia Commons; Author:Don Stalons (1974)

Pulpy kidney is a common, peracute and usually fatal enterotoxaemia of sheep of all ages, caused by the ε toxin of Clostridium perfringens type D. C. perfringens is a large, gram positive, anaerobic bacillus that is ubiquitous in the environment and commensalises the gastrointestinal tract of most mammals¹, although type D is found less abundantly in healthy animals than the other genotypes^ivis. Five genotypes of Clostridium perfringens exist, named A-E, and all genotypes produce potent exotoxins. There are 12 exotoxins in total, some of which are lethal and others which are of minor significance². These are produced as pro-toxins, and are converted to their toxic forms by digestive enzymes such as trypsin. The enterotoxaemias are a group of diseases caused by proliferation of C. perfringens in the lumen of the gastrointestinal tract and excessive production of exotoxin.

In healthy animals, there is a balance between multiplication of Clostridium perfringens and its passage in the faeces. This ensures that infection is maintained at a low level. However, C. perfringens is saccharolytic and is therefore able to multiply rapidly when large quantities of fermentable carbohydrate are introduced to the anaerobic conditions of the abomasum and small intestine, leading to build-up of exotoxin. Gut statis, for example due to insufficient dietray fibre or a high gastrointestinal parasite burden, can also contribute to the accumulation of toxins.

Enterotoxaemia due to Clostridium perfringens type D causes sudden death in sheep of any age, particularly well-grown lambs of between 4 and 10 weeks of age and fattening lambs of 6 months to 1 year old^lewis. Rams are also susceptible when they are subjected to an incraesed plane of nutrition prior to mating. The condition is associated with a change in diet, for example to include lush grass or high proportions of concentrate. This leads to rapid multiplication of the bacterium and excessive production of its ε toxin. ε toxin causes loss of epithelial integrity, leading to increased capiliary permeability and oedema formation in many tissues, particularly the brain^{merck, ivis}. The incidence of pulpy kidney declined over the past 25 years or so, due to the widespread use of clostridial vaccines^sargison, but the condition is now becoming a problem again as complacency reduces the use of vaccination. At its most extreme, pulpy kidney can cause losses of 10-15% of the lamb crop. The disease can also occur in cattle, but this is rare^ivis.

Signalment

Pulpy kidney can affect unvaccinated sheep of all ages. However, it is most common in 4-10 week old lambs, and fattening lambs between 6 months and 1 year of age.

Diagnosis

A presumptive diagnosis of pulpy kidney can be made based on a history of sudden deaths in lambs recently introduced to carbohydrate-rich feed. If animals are seen before they die, certain clinical signs may be suggestive of pulpy kidney, and post-mortem examination may also aid diagnosis. Laboratory tests support, but do not confirm, a diagnosis of pulpy kidney.

Clinical Signs

The first indication of pulpy kidney disease is the occurence of sudden death in the best-grown lambs^{merck, lewis, ivis}. Occasionally, animals may be seen alive displaying clinical signs suggestive of the condition. Signs are typically neurological and include hyperaesthesia, ataxia, circling or head-pressing, with rapid progression to recumbency, opisthotonus, convulsions and death^{merck, lewis, ivis}. Diarrhoea may also be seen, and hyperglycemia or glycosuria is frequently reported^{merck, lewis}.

Adult sheep are sometimes affected and show weakness, incoordination, and convulsions. Death occurs within 24 hours^merck.

Laboratory Tests

diseases of sheep: intestinal contents will be positive for episilon toxin but negative for beta toxin. Anaerobic cultures will yield C. perfringens, usually in pure culture. These can be confirmed as C. perfringens type d by PCR techniques. Short, thick gram-positive rods are easily visualised on smears of intestinal contents. An ELISA may be used to demonstrate the presence of ɛ toxin in the small intestinal or peritoneal fluid. A positive toxin ELISA supports but does not confirm a diagnosis, since immune animals may experience elevated toxin levels without suffering ill effects. PCR can also be used to identify ɛ toxin indirectly by detecting its gene.

Pathology

Neurologic signs are explained by lesions in the central nervous system, which are most specific and diagnostic for the disease. These consist of bilatterally symmetrical focal malacia of the basal ganglia, substantia nigra and thalamus and bilaterally symmetrical demyelination in the internal capsule, subcortical white matter and cerebellar peduncles. The harmful effect of the toxin on endothelium is particularly obvious in the brain. Damaged endothelial cells develop pyknotic nucelei and the vessels become surrounded by oedema. Ultrastructurally, the perivascular astrocyte end-feet are markedly swollen.

The ultrastructural changes on experimental disease consist of periaxonal and intramyelinic oedema in cerebellar white matter and swelling of axon terminals and dendrites in grey matter adjacent to lateral ventricles. Swelling of mitochondria is also an early feature. Occlusion of capillaries by aggregated platelets, accompanied by petechiae in relation to the malacia, suggests that changes in vascular endothelium may be the primary effect of the toxin. This concept is supported by eveidence that the capillaries in affected parts of the brain leak consipcuously within 90 minutes after administration of C. perfringens type D toxin.

Pulpy kidney disease- histological (Courtesy of Bristol BioMed Image Archive)

Pulpy kidney disease- gross (Courtesy of Bristol BioMed Image Archive)

In young lambs, the only change observable on post-mortem examination may be the presence of a few hyperaemic areas on the intestine and a fluid-filled pericardial sac^merck. Intestinal lesions may even be absent^ivis. Animals, particularly older ones, may have myocardial haemorrhages as well as petechiation of visceral surfaces and abdominal muscles^{merck, ivis}. Pulmonary oedema and congestion is often present and there may be pleural, peritoneal or pericardial effusio. The fluid is variable in volume and can be straw or red coloured, sometimes containing fibrin clots^ivis. The kidneys often rapidly autolyse, as suggested by the name "pulpy kidney", but this is not a pathognomic finding. The thalamus and cerebellum may alo be abnormally soft, perhaps containing haemorrhages^{merk, ivis}.

Treatment and Control

Presentation of lamb dysentery is usually peracute, with sudden deaths occuring before treatment can be implemented. Even if animals are found prior to death, treatment is usually unrewarding as organs are irreversibly damaged by toxins by the time signs present². Instead, a definitive diagnosis should be pursued before greater losses occur, and the farmer should be encouraged to submit the carcase for further investigations.

As treatment is so ineffective, much emphasis is put on to the control of lamb dysentery. Vaccination in the face of an outbreak has been shown to be effective⁷, and specific hyperimmune serum can also be administered^{4, 6t}. Oral antibiotics may be given⁴ but are regarded as a less appropriate therepautic. Management measures such as removing the flock from a particular pasture or reducing concentrate feeding may be implemented in other clostridial diseases but are of no benefit in lamb dysentery: over-ingestion of the dam's milk combined with poor hygiene are responsible for this disease. Therefore, sufficient supervision should be given at lambing time to ensure adequate intakes of colostrium and the maintenance of good hygiene.

Lamb dysentery can be controlled through vaccination against clostridial diseases. Before the development of modern clostridial vaccines in the 1970s, catastrophic losses of up to 30% of the lamb crop could occur due to lamb dysentery². The vaccines used today are effective against a variety of clostridial diseases and some vaccines are combined for effects against Pasteurella. The vaccines consist of toxoids which are inactivated forms of the toxins produced by clostridial organisms. The principles of vaccination are the same whether a clostridium-only or Pasteurella-combined product is used: a sensitising dose must be given 4-6 weeks before a second, confirming dose². As immunity wanes over a period of a year booster doses are required annually. Therefore, ewes should receive the primary vaccination course before entering the breeding flock and an annual booster approximately six weeks before lambing. Timing the booster vaccination in this way affords passive protection to lambs until they are around sixteen weeks of age. Lambs born to unvaccinated ewes should be vaccinated between 3 and 12 weeks old, with a second injection given at least four weeks later.

Links

• The Merck Veterinary Manual: Pulpy Kidney
• The Center for Food Security and Public Health Animal Disease Factsheet: Epsilon toxin of Clostridium perfringens.
• NOAH: Vaccination of farm animals
• Clostridia.net - Clostridium perfringens

References

1. Jones, T C et al (1997) Veterinary Pathology, Wiley-Blackwell.